Keep yourself up to date
SEATTLE, October 17, 2017 — Lucas Nivon, CEO of Cyrus Biotechnology, today will lead a panel on recent advances in computational protein engineering at LabCentral in Cambridge, MA. Computationally designed therapeutic proteins are in the clinic, and computationally optimized enzymes are producing ingredients of value sustainably and cost effectively. Dr. Nivon will present an […]
Cyrus raised $8M in a series A financing round. Geekwire talked with Cyrus CEO Lucas Nivon about the positive implications of this funding for the future of Cyrus.
Bench® software increases access to cutting edge technology which can speed design and development of new therapies, consumer products Seattle, WA July 27, 2017 — Cyrus Biotechnology, Inc., a Seattle-based biotechnology software firm offering an advanced computational tool for protein modeling and design to accelerate new drug discovery, today announced the closing of […]
SEATTLE, April 20, 2017 — Cyrus Biotechnology, Inc., a new biotechnology software company offering the most advanced protein modeling and design capabilities to the Biopharmaceutical, Synthetic Biology, Chemical, and Consumer Products industries is pleased to announce its participation in the 13th Annual PEGS Boston Protein Engineering Summit in Boston, from May 1st through May 4th. […]
SEATTLE, April 3, 2017 — Cyrus Biotechnology, Inc., a new biotechnology software company offering the most advanced protein modeling and design capabilities to the Biopharmaceutical, Synthetic Biology, Chemical, and Consumer Products industries is pleased to announce its participation to the American Chemical Society Spring Meeting in San Francisco on April 3rd, 2017. Dr. Lucas Nivon, […]